David
Santamaría Velilla
Institute Catalá Oncología
Barcelona, EspañaPublications en collaboration avec des chercheurs de Institute Catalá Oncología (3)
2024
-
RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade
Nature Communications, Vol. 15, Núm. 1
2016
-
Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma
Nature Medicine, Vol. 22, Núm. 3, pp. 270-277
-
KRAS-driven lung adenocarcinoma: Combined DDR1/Notch inhibition as an effective therapy
ESMO Open, Vol. 1, Núm. 5